MeSH Browser

MeSH Heading: Supranuclear Palsy, Progressive
Tree Number(s): C10.228.140.079.882; C10.228.662.700; C10.292.562.750.500; C10.574.945.500; C10.597.622.447.690; C11.590.472.500; C23.888.592.636.447.690
Unique ID: D013494
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D013494
Scope Note: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
Entry Term(s): Ophthalmoplegia, Progressive Supranuclear; Palsy, Progressive Supranuclear; Progressive Supranuclear Ophthalmoplegia; Progressive Supranuclear Palsy; Progressive Supranuclear Palsy 1; Richardson's Syndrome; Steele-Richardson-Olszewski Disease; Steele-Richardson-Olszewski Syndrome; Supranuclear Palsy, Progressive, 1
NLM Classification #: WL 358.5
Previous Indexing: Ophthalmoplegia (1979-1986); Paralysis (1966-1986); Paralysis, Bulbar (1966-1986)
Public MeSH Note: 1987
History Note: 1987
Date Established: 1987/01/01
Date of Entry: 1986/04/01
Revision Date: 2020/02/06

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

classification (CL)

complications (CO)

congenital (CN)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

urine (UR)

veterinary (VE)

virology (VI)

Concept UI: M0020849
Scope Note: A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
Terms: Supranuclear Palsy, Progressive Preferred Term
Term UI T039601
Date01/01/1999
LexicalTag NON
ThesaurusID; Palsy, Progressive Supranuclear
Term UI T039600
Date04/01/1986
LexicalTag NON
ThesaurusID UNK (19XX); Progressive Supranuclear Palsy
Term UI T842339
Date04/18/2013
LexicalTag NON
ThesaurusID GHR (2014); Richardson's Syndrome
Term UI T842340
Date04/18/2013
LexicalTag EPO
ThesaurusID GHR (2014); Steele-Richardson-Olszewski Disease
Term UI T364587
Date11/03/1999
LexicalTag EPO
ThesaurusID NLM (2000); Steele-Richardson-Olszewski Syndrome
Term UI T039599
Date04/01/1986
LexicalTag EPO
ThesaurusID

Supranuclear Palsy, Progressive MeSH Descriptor Data 2025